Neonatal Stem Cell Transplantation and Regenerative Medicine
Stem cell transplantation (SCT) is rare in neonates or infants, there has been some research reporting an encouraging survival rate; as well as there are studies pointing SCT in infants as a controversial treatment. Lung diseases remain one of the main causes of morbidity and mortality in neonates. Cell therapy and regenerative medicine have the potential to revolutionize the management of life-threatening and debilitating lung diseases that currently lack effective treatments.
Related Conference of Neonatal Stem Cell Transplantation and Regenerative Medicine
June 29-30, 2026
35th International Conference on Pediatrics, Neonatology and Pediatric Nursing
Barcelona, Spain
July 06-07, 2026
10th Annual World Congress on Pediatric Nutrition, Gastroenterology and Child Development
Barcelona, Spain
August 10-11, 2026
42nd International Conference on Pediatric and Nutritional Research
Toronto, Canada
August 24-25, 2026
12th International Conference on Pediatrics Research and Adolescent Medicine
London, UK
September 17-18, 2026
8th International Conference on Pediatrics, Neonatology and Healthcare
London, UK
October 19-20, 2026
18th World Congress on Pediatrics, Neonatology and Pediatric Surgery
Paris, France
November 12-13, 2026
7th International Conference on Pediatrics, Child Health and Emergency Care
Barcelona, Spain
February 18-19, 2027
24th International Conference on Pediatrics and Pediatric Cardiology
Paris, France
March 22-23, 2027
10th International Pediatrics, Infectious Diseases and Healthcare Conference
Singapore City, Singapore

